The somatogenic hormones and insulin-like growth factor-1: Stimulators of lymphopoiesis and immune function

Endocrine Reviews

Volumn 18, Issue 2, 1997, Pages 157-179

  Clark, Ross ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; GROWTH FACTOR; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; PROLACTIN; PROLACTIN RECEPTOR; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR;

APOPTOSIS; BONE MARROW; GASTROINTESTINAL TRACT; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HUMAN; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; LYMPHOPOIESIS; NONHUMAN; POLYCYTHEMIA VERA; PREGNANCY; PRIORITY JOURNAL; PROLACTIN RELEASE; REVIEW; SIGNAL TRANSDUCTION; STRESS; THYMUS;

EID: 0030999190     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/edrv.18.2.0296     Document Type: Review

References (287)

1. Smith P 1930 The effect of hypophysectomy upon the involution of the thymus in the rat. Anat Rec 47:119-143
2. Nagy E, Berczi I 1978 Immunodeficiency in hypophysectomized rats. Acta Endocrinol (Copenh) 89:530-537
3. Berczi I, Nagy E 1991 Effects of hypophysectomy on immune function. In: Ader R, Felten DL, Cohen N (eds) Psychoneuroimmunology II. Academic Press, New York, pp 339-375
4. Lundin PM 1958 Anterior pituitary gland and lymphoid tissue growth. Acta Endocrinol (Copenh) 28[Suppl 40]:
5. Everitt AV, Cavanagh LM 1965 The aging process in the hypophysectomised rat. Gerontologia 11:198-207
6. Berczi I, Nagy E, Kovacs K, Horvath E 1981 Regulation of humoral immunity in rats by pituitary hormones. Acta Endocrinol (Copenh) 98:506-513
7. Pierpaoli W, Baroni C, Fabris N, Sorkin E 1969 Hormones and immunological capacity. II. Reconstitution of antibody production in hormonally deficient mice by somatotropic hormone, thyrotropic hormone, and thyroxin. Immunology 16:217-230
8. Fabris N, Pieropaoli W, Sorkin E 1972 Lymphocytes, hormones and ageing. Nature 240:557-559
9. Besedovsky HO, Rey AD 1996 Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 17:64-102
10. Grossman CJ 1984 Regulation of the immune system by sex steroids. Endocr Rev 5:435-455
11. Bateman A, Singh A, Kral T, Solomon S 1989 The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev 10:92-112
12. Munck A, Guyre PM 1991 Glucocorticoids and immune function. In: Ader R, Felten D, Cohen N (eds) Psychoneuroimmunology. Academic Press, New York, pp 447-513
13. McCruden AB, Stimson WH 1991 Sex hormones and immune function. In: Ader R, Felten DL, Cohen N (eds) Psychoneuroimmunology. Academic Press, New York, pp 475-493
14. Berton EW, Bryant HU, Holaday JW 1991 Prolactin and immune function. In: Ader R, Felten DL, Cohen N (eds) Psychoneuroimmunology. Academic Press, New York, pp 403-428
15. Kelley KW 1991 Growth hormone in immunobiology. In: Ader R, Felten DL, Cohen N (eds) Psychoneuroimmunology. Academic Press, New York, pp 377-402
16. Berczi I 1994 The role of the growth and lactogenic hormone family in immune function. Neuroimmunomodulation 1:201-216
17. Fabris N, Mocchegani E, Mariotti S, Pacini F, Pinchera A 1989 Thyroid-thymus interactions during development and aging. Horm Res 31:85-89
18. Zimmet P, Ng F, Bornstein J, Taft P 1972 Somantin (In-G), cataglykin (Ac-G), and glucose homeostasis in man. Horm Metab Res 4:309-310
19. Salter J, Best GH 1953 Insulin as a growth hormone. Br Med J 2:353-356
20. Wagner EM, Scow RO 1957 Effect of insulin on growth in force-fed hypophysectomized rats. Endocrinology 61:419-425
21. Young FG 1967 Insulin and the action of growth hormone. In: Pecile A, Muller EE (eds) Growth Hormone: Proceedings of the First International Symposium. Excerpta Medica Foundation, Amsterdam, pp 139-152
22. Salmon JWD, Daughaday WH 1957 A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 68:825-836
23. Salmon JWD, Duvall MR 1970 In vitro stimulation of leucine incorporation into muscle and cartilage protein by a serum fraction with sulfation factor activity: differentiation of effects from those of growth hormone and insulin. Endocrinology 87:1168-1180
24. Daughaday WH, Hall K, Raben MS, Salmon WD, van den Brande JL, VanWyk JJ 1972 Somatomedin: proposed designation for sulfation factor. Nature 235:107-108
25. Rinderknecht E, Humbel RE 1978 The amino sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 253:2769-2776
26. Rinderknecht E, Humbel RE 1978 Primary structure of human insulin-like growth factor II. FEBS Lett 89:283-286
27. Froesch ER, Muller WA, Burgi H 1966 Nonsuppressible insulin-like activity of human serum. II Biological properties of plasma extracts with nonsuppressible insulin-like activity. Biochim Biophys Acta 121:360-374
28. Schoenle E, Zapf J, Humbel RE, Froesch ER 1982 Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature 296:252-253
29. Zapf J, Hunziker EB 1994 The somatomedin hypothesis revisited: differential effects of growth hormone and IGF-I on skeletal growth of the rat in vivo. In: Baxter RC, Gluckman PD, Rosenfeld RG (eds) The Insulin-like Growth Factors and Their Regulatory Proteins. Elsevier, Amsterdam, pp 381-391
30. Skottner A, Clark RG, Fryklund L, Robinson ICAF 1989 Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I. Endocrinology 124:2519-2526
31. Guler H, Zapf J, Scheiwiller E, Froesch E 1988 Recombinant human insulin-like growth factor 1 stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 85:4889-4893
32. Greene H, Morikawa M, Nixon T 1985 A dual effector theory of growth hormone action. Differentiation 29:195-198
33. Underwood LE, Clemmons DR 1994 Prospects of therapy with IGF-1 for catabolic conditions. In: Baxter RC, Gluckman PD, Rosenfeld RG (eds) The Insulin-like Growth Factors and Their Regulatory Proteins. Elsevier, Amsterdam, pp 449-456
34. Murphy WJ, Rui H, Longo DL 1995 Effects of growth hormone and prolactin immune development and function. Life Sci 57:1-14
35. Kelley KW, Arkins S, Li YM 1994 Role of growth hormone and insulin-like growth factor I in immunoregulation. In: Bereu BB, Walker RF (eds) Growth Hormone II: Basic and Clinical Aspects. Springer-Verlag, New York, pp 87-103
36. Kelley KW, Arkins S 1994 A role for IGF-1 during myeloid cell growth and differentiation. In: Baxter RC, Gluckman PD, Rosenfeld RG (eds) The Insulin-like Growth Factors and Their Regulatory Proteins. Elsevier, Amsterdam, pp 315-327
37. Weigent DA, Blalock JE 1994 Production and function of growth hormone in the immune system. In: Bereu BB, Walker RF (eds) Growth Hormone II: Basic and Clinical Aspects. Springer-Verlag, New York, pp 104-115
38. Fabris N, Mocchegiani E 1994 Immunomodulating role of growth hormone. In: Bercu BB, Walker RF (eds) Growth Hormone II: Basic and Clinical Aspects. Springer-Verlag, New York, pp 116-130
39. Auernhammer CJ, Strasburger CJ 1995 Effects of growth hormone and insulin-like growth factor on the immune system. Eur J Endocrinol 133:635-645
40. Horseman ND, Yu-Lee L-Y 1994 Transcriptional regulation by the helix-bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines. Endocr Rev 15:627-649
41. Hooghe-Peters EL, Hooghe R (eds) 1995 Growth hormone, prolactin, and IGF-1 as lymphohemopoietic cytokines. RG Landes Company, Austin, TX, p 262
42. Baumann G 1991 Growth hormone heterogeneity: genes, isohormone variants and binding proteins. Endocr Rev 12:434-449
43. Mol JA, van Garderen E, Selman PJ, Wolfswinkel J, Rijinberk A, Rutteman GR 1995 Growth hormone mRNA in mammary gland tumors of dogs and cats. J Clin Invest 95:2028-2034
44. Mol JA, Henzen-Logmans SC, Hageman P, Misdorp W 1995 Expression of the gene encoding growth hormone in the human mammary gland. J Clin Endocrinol Metab 80:3094-3096
45. Weigent DA, Baxter JB, Wear WE, Smith LR, Smith LR, Bost KL, Blalock JE 1988 Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J 2:2812-2818
46. Hattori N, Shimatsu A, Sugita M, Kumagai S, Imura H 1990 Immunoreactive growth hormone (GH) secretion by human lymphocytes: augmented release by exogenous GH. Biochem Biophys Res Commun 168:396-401
47. Weigent DA, Riley JE, Galin FS, LeBoeuf RD, Blalock JE 1991 Detection of GH and GHRH-related messenger RNA in rat lymphocytes by the polymerase chain reaction. Proc Soc Exp Biol Med 198:643-648
48. Weigent DA, LeBoeuf RD, Blalock JE 1991 An anti-sense oligonucleotide to growth hormone mRNA inhibits lymphocyte proliferation. Endocrinology 128:2053-2057
49. Varma S, Sabharwal P, Sheridan JF, Malarkey WB 1993 Growth hormone secretion by human peripheral blood mononuclear cells detected by an enzyme-linked immunoplaque assay. J Clin Endocrinol Metab 76:49-53
50. Kao TL, Harbour D, Meyer IWJ 1992 Immunoreactive growth hormone production by cultured lymphocytes. Ann NY Acad Sci 650:179-181
51. Lytras A, Quan N, Vrontakis ME, Shaw JE, Cattini PA, Friesen HG 1993 Growth hormone expression in human Burkitt lymphoma serum-free ramos cell line. Endocrinology 132:620-628
52. Wu H, Devi R, Malarkey WB 1996 Localization of growth hormone messenger ribonucleic acid in the human immune system: a clinical research center study. J Clin Endocrinol Metab 81:1278-1282
53. Binder G, Revskoy S, Gupta D 1994 In vivo growth hormone gene expression in neonatal rat thymus and bone marrow. J Endocrinol 140:137-143
54. Theill LE, Karin M 1993 Transcriptional control of GH expression and anterior pituitary development. Endocr Rev 14:670-689
55. Delhase M, Vergani P, Malur A, Hooghe-Peters EL, Hooghe RJ 1993 The transcription factor Pit-1/GHF-1 is expressed in hemopoietic and lymphoid tissues. Eur J Immunol 23:951-955
56. Frohman LA, Downs TA, Chomcynski P 1992 Regulation of growth hormone secretion. Front Neuroendocrinol 13:344-405
57. Stephanou A, Knight RA, Lightman SL 1991 Production of a growth hormone-releasing hormone-like peptide and its mRNA by human lymphocytes. Neuroendocrinology 53:628-633
58. Aguila MC, Dess WL, Haensly WE, McCann SM 1991 Evidence that somatostatin is localized and synthesized in lymphoid organs. Proc Natl Acad Sci USA 88:11485-11489
59. Bhathena SJ, Louie J, Schechter GP, Redman S, Wahl L, Recant L 1981 Identification of human mononuclear leukocytes bearing receptors for somatostatin and glucagon. Diabetes 30:127-131
60. Hattori N, Ikekubo K, Ishihara T, Moridera K, Hino M, Kurahachi H 1994 Spontaneous growth hormone (GH) secretion by unstimulated human lymphocytes and the effects of GH-releasing hormone and somatostatin. J Clin Endocrinol Metab 79:1678-1680
61. Valtora A, Moretta A, Maccario R, Bozzola M, Severi F 1991 Influence of growth hormone-releasing hormone (GHRH) on phytohemaglutinin-induced lymphocyte activation: comparison of two synthetic forms. Thymus 18:51-59
62. Zelazowski P, Dohler KD, Stepien H, Pawilowski M 1989 Effect of growth hormone releasing hormone on human peripheral blood leukocyte chemotaxis and migration in normal subjects. Neuroendocrinology 50:236-239
63. Serri O, Brazeau P, Kachra Z, Posner B 1992 Octreotide inhibits insulin-like growth factor-I hepatic gene expression in the hypophysectomized rat: evidence for a direct and indirect mechanism of action. Endocrinology 130:1816-1821
64. Campbell RM, Scanes CG 1995 Endocrine peptides "moonlighting" as immune modulators: roles for somatostatin and GH-releasing factor. J Endocrinol 147:383-396
65. Hattori H, Shimomura K, Ishihara T, Moridera K, Hino M, Ikekubo K 1993 Growth hormone (GH) secretion from human lymphocytes is up-regulated by GH but not by insulin-like growth factor-I. J Clin Endocrinol Metab 76:937-939
66. Hiestand PC, Mekler P, Nordmann R, Grieder A, Permongkol C 1986 Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proc Natl Acad Sci USA 83:2599-2603
67. 125I human growth hormone to specific receptors in human cultured lymphocytes. J Biol Chem 249:1661-1667
68. Kiess W, Butenandt O 1985 Specific growth hormone receptors on human peripheral mononuclear cells: reexpression, identification and characterization. J Clin Endocrinol Metab 60:740-746
69. Barnard R, Bundensen PG, Rylatt DB, Waters MJ 1985 Evidence from the use of monoclonal antibody probes for structural heterogeneity of the growth hormone receptor. Biochem J 231:459-468
70. Badolato R, Bond HM, Valerio G, Petrella A, Morrone G, Waters MJ, Venuta S, Tenore A 1994 Differential expression of surface membrane growth hormone receptor on human peripheral blood lymphocytes detected by dual fluorochrome flow. J Clin Endocrinol Metab 79:984-990
71. Hansen B, Hijorth S, Welinder B, Skriver L, De Meyts P 1993 The growth hormone (hGH)-binding protein cloned from human IM-9 lymphocytes modulates the down-regulation of hGH receptors by 22- and 20-kilodalton human hGH in IM-9 lymphocytes and the biological effects of the hormone in Nb2 lymphoma cells. Endocrinology 133:2809-2817
72. Mercado M, Da Vila N, McLeod JF, Baumann G 1994 Distribution of growth hormone receptor messenger ribonucleic acid containing and lacking exon 3 in human tissues. J Clin Endocrinol Metab 78:731-735
73. Leung DW, Spencer SA, Cachianes G, Waters MJ, Wood WI 1987 Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330:537-543
74. Rapaport R, Sills IN, Green L, Barrett P, Labus J, Skuza KA, Chartoff A, Goode L, Stene M, Petersen BH 1995 Detection of human growth hormone receptors on IM-9 cells and peripheral blood mononuclear cell subsets by flow cytometry: correlation with growth hormone-binding protein levels. J Clin Endocrinol Metab 80:2612-2619
75. Cunningham BC, Ultsch M, de Vos A, Mulkerrin M, Clauser K, Wells J 1991 Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254:821-825
76. de Vos A, Ultsch M, Kossiakoff AA 1992 Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:307-312
77. Bazan JF 1989 A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors and the p75 IL-2 receptor B-chain. Biochem Biophys Res Commun 164:788-795
78. Schindler C, Darnell JEJ 1995 Transcriptional responses to polypeptide ligands: the JAK/STAT pathway. Annu Rev Biochem 64:621-651
79. Meraz MA, While JM, Sheehan KCF, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenland AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Auget M, Schreiber RD 1996 Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431-442
80. Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, Wells JA 1992 Rational design of potent antagonists to the human growth hormone receptor. Science 256:1677-1680
81. Mode A, Tollet P, Wells T, Carmignac DF, Clark RG, Chen WY, Kopchick JJ, Robinson ICAF 1996 The human GH (hGH) antagonist G120RhGH does not antagonize GH in the rat, but has paradoxical agonist activity, probably via the PRL receptor. Endocrinology 137:447-454
82. Hirokawa K, Makinodan T 1975 Thymus involution: effect on T cell differentiation. J Immunol 6:1659-1664
83. Boyd E 1932 The weight of the thymus in health and disease. Am J Dis Child 43:1162-1214
84. Miller JFAP 1961 The immunological role of the thymus. Lancet 2:748-749
85. Corpas E, Harman S, Blackman M 1993 Human growth hormone and aging. Endocr Rev 14:20-39
86. Juul A, Bang P, Hertel N, Main K, Dalgaard P, Jorgenson K, Muller J, Hall K, Skakkebaek NE 1994 Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size and body mass index. J Clin Endocrinol Metab 78:744-752
87. Juul A, Main K, Blum W, Lindholm J, Ranke M, Skakkebaek NE 1994 The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol (Oxf) 41:85-93
88. Roth JA, Kaeberle ML, Grier RL, Hopper JG, Spiegel HE, McAllister HA 1984 Improvement in clinical condition and thymus morphological features associated with growth hormone treatment of immunodeficient dwarf dogs. Am J Vet Res 45:1151-1155
89. Goff BL, Roth JA, Arp LH, Incefy GS 1987 Growth hormone treatment stimulates thymulin production in aged dogs. Clin Exp Immunol 68:580-587
90. Monroe WE, Roth JA, Grier RL, Arp LH, Naylor PH 1987 Effects of growth hormone on the adult canine thymus. Thymus 9:173-187
91. Kelley KW, Brief S, Westly HJ, Novakofski J, Bechtel PJ, Simon J, Walker EB 1986 GH3 pituitary adenoma cells can reverse thymic aging in rats. Proc Natl Acad Sci USA 83:5663-5667
92. Clark R, Strasser J, McCabe S, Robbins K, Jardieu P 1993 Insulin-like growth factor-1 stimulation of lymphopoiesis. J Clin Invest 92:540-548
93. Timsit J, Savino W, Safieh B, Chanson P, Gagnerault MC, Bach JF 1992 Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. J Clin Endocrinol Metab 75:183-188
94. Maiter D, Underwood LE, Maes M, Davenport ML, Ketelslegers JM 1988 Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats. Endocrinology 123:1053-1059
95. Tauber MT, Du PH, SallerinCaute B, Rochiccioli P, Bastide R 1993 Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion vs. daily injection of recombinant human GH in GH-deficient children. J Clin Endocrinol Metab 76:1135-1139
96. Clark RG, Robinson ICAF 1987 The control and significance of the secretory pattern of growth hormone in the rat. In: Isaksson O, Binder K, Hall K, Hokfelt B (eds) Growth Hormone Basic and Clinical Aspects. Elsevier, Amsterdam, pp 109-128
97. Mode A, Norstedt G, Simic B, Eneroth P, Gustafsson JA 1981 Continuous infusion of growth hormone feminizes hepatic steroid metabolism in the rat. Endocrinology 108:2103-2108
98. Clark RG, Mortensen DL, Carlsson L, Carmignac D, Robinson ICAF 1995 Growth responses to patterned GH delivery. Endocrine 3:717-723
99. Clark RG, Mortensen DL, Carlsson LMS, Carlsson B, Carmignac D, Robinson ICAF 1996 The obese growth hormone (GH)-deficient dwarf rat: body fat responses to patterned delivery of GH and insulin-like growth factor-I. Endocrinology 137:1904-1912
100. Cecim M, Bartke A, Yun JG, Wagner TE 1993 Growth allometry of transgenic mice expressing the mouse metallothionein-I/bovine growth hormone gene. Transgene 1:125-132
101. Bernton E, Dave J 1991 Prolactin, growth hormone and immune homeostasis. In: Meltzer MS, Mantovani A (eds) Cellular and Cytokine Networks in Tissue Immunity. Wiley-Liss, New York, pp 69-75
102. Wise T, Klindt J, Buonomo FC, Yen JT 1994 Effects of porcine somatotropin on thymic weight, thymosin alpha 1, and thymosin beta4 in gilts and barrows. In: Bereu BB, Walker RF (eds) Growth Hormone II: Basic and Clinical Aspects. Springer-Verlag, New York, pp 317-327
103. Clark RG, Olsen K, Fuh G, Marian M, Mortensen DL, Teshima G, Chang S, Chu H, Muuku V, Canova-Davis E, Somers T, Cronin M, Winkler M, Wells J 1996 Long-acting growth hormones produced by conjugation with polyethylene glycol. J Biol Chem 271: 21969-21977
104. Johnson OL, Cleland JL, Lee HJ, Charnis M, Duenas E, Jaworowicz W, Shepard D, Shahazamani A, Jones AJS, Putney SD 1996 A month-long effect from a single injection of microencapsulated human growth hormone. Nature Medicine 2:795-799
105. Adler WH, Nagel JE, Harman SM, Corpas E, Blackman MR 1995 Growth hormone and immune function in the elderly. In: Blackman MR, Roth J, Harman SM, Shapiro JR (eds) GHRH, GH and IGF-1: Basic and Clinical Advances. Springer-Verlag, New York, pp 277-290
106. Hirano T 1991 Interleukin-6. In: Thomson AW (eds) The Cytokine Handbook. Harcourt Brace Jovanovich, San Diego, CA, pp 169-190
107. Woodroofe C, Muller W, Ruther U 1992 Long-term consequences of interleukin-2 overexpression in transgenic mice. DNA Cell Biol 11:587-592
108. Kundig TM, Schorle H, Bachmann MF, Hengartner H, Zinkernagel RM, Horak I 1993 Immune responses in interleukin-2-deficient mice. Science 262:1059-1061
109. Clark RG, Mortensen DL, Carlsson LMS, Spencer SA, McKay P, Mulkerrin M, Moore J, Cunningham BC 1996 Recombinant human growth hormone (GH)-binding protein enhances the growth-promoting activity of human GH in the rat. Endocrinology 137: 4308-4315
110. Rosenfeld RG, Rosenblom AL, Guevara-Aguirre J 1994 Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 15:369-390
111. Hwang P, Guyda H, Friesen H 1972 Purification of human prolactin. J Biol Chem 247:1955-1958
112. Montgomery DW, Zukoski CF, Shah GN, Buckley AR, Pacholczyk T, Russell DH 1987 Concanavalin A-stimulated murine splenocytes produce a factor with prolactin-like bioactivity and immunoreactivity. Biochem Biophys Res Commun 145:692-698
113. Sabharwal P, Glaser R, Lafuse W, Varma S, Liu Q, Arkins S, Kooijman R, Kutz L, Kelley KW, Malarkey WB 1992 Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation. Proc Natl Acad Sci USA 89:7713-7716
114. Hartmann DP, Holaday JW, Bernton EW 1989 Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB J 3:2194-2202
115. Shah GN, Laird II HE, Russell DH 1991 Identification and characterization of a prolactin-like polypeptide synthesized by mitogen-stimulated murine lymphocytes. Int Immunol 3:297-304
116. Pellegrini I, Lebrun JJ, Ali S, Kelly PA 1992 Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol 6:1023-1031
117. Touraine P, Leite de Moraes MC, Dardenne M, Kelly PA 1994 Expression of short and long forms of prolactin receptor in murine lymphoid tissues. Mol Cell Endocrinol 104:183-190
118. Le Provost F, Leroux C, Martin P, Gaye P, Dijane J 1994 Prolactin gene expression in ovine and caprine mammary gland. Neuroendocrinology 60:305-313
119. Tanaka T, Shiu RPC, Gout PW, Beer CT, Noble RL, Friesen HG 1980 A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab 51:1058-1063
120. Russell DH, Kibler R, Matrisian L, Larson DF, Poulos B, Magun BE 1985 Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. J Immunol 134: 3027-3031
121. Dardenne M, Leite de Moraes MC, Kelly PA, Gagnerault MC 1994 Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytometry. Endocrinology 134:2108-2114
122. Gagnerault MC, Touraine P, Savino W, Kelly PA, Dardenne M 1993 Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J Immunol 150:5673-5681
123. Koh CY, Phillips JT 1993 Prolactin receptor expression by lymphoid tissues in normal and immunized rats. Mol Cell Endocrinol 92:R21-R25
124. Gala RR, Shevach EM 1993 Identification by analytical flow cytometry of prolactin receptors on immunocompetent cell populations in the mouse. Endocrinology 133:1617-1623
125. Dardenne M, Kelly PA, Bach JF, Savino W 1991 Identification and functional activity of prolactin receptors in thymic epithelial cells. Proc Natl Acad Sci USA 88:9700-9704
126. Nagy E, Berczi I, Friesen HG 1983 Regulation of immunity in rats by lactogenic hormones. Acta Endocrinol (Copenh) 102:351-357
127. Nagy E, Berczi I 1991 Hypophysectomized rats depend on residual prolactin for survival. Endocrinology 128:2776-2784
128. Paesi FGS, de Jong SE 1954 Growth inhibition by estrogen in hypophysectomized rats. Acta Physiol Pharmacol 3:227-231
129. Morikawa K, Oseko F, Morikawa S 1993 Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro. Clin Exp Immunol 93:200-205
130. Morikawa K, Oseko F, Morikawa S 1995 Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro. Clin Exp Immunol 95:514-518
131. Wilner ML, Ettenger RB, Koyle MA, Rosenthal JT 1990 The effect of hypoprolactinemia alone an in combination with cyclosporine on allograft rejection. Transplantation 49:264-267
132. Carrier M, Wild J, Pelletier LC, Copeland JG 1990 Bromocriptine as an adjuvant to cyclosporine immunosuppression after heart transplantation. Ann Thorac Surg 49:129-132
133. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
134. Straus DS, Hayden JM, Marten NW 1994 Molecular mechanisms for nutritional regulation of genes for IGF-I, IGF-binding proteins and other plasma proteins. In: Baxter RC, Gluckman PD, Rosenfeld RG (eds) The Insulin-like Growth Factors and Their Regulatory Proteins. Elsevier, Amsterdam, pp 33-41
135. Oster MH, Fielder P, Levin N, Cronin MJ 1995 Adaptation of the growth hormone and insulin-like growth factor-I axis to chronic and severe calorie or protein malnutrition. J Clin Invest 95:2258-2265
136. Isaksson OGP, Lindahl A, Nilsson A, Isgaard J 1987 Cellular mechanism(s) for the stimulatory effect of growth hormone on longitudinal bone growth. In: Isaksson O, Binder C, Hall K, Hokfelt B (eds) Growth Hormone Basic and Clinical Aspects. Excerpta Medica, Amsterdam, pp 307-320
137. Kurtz A, Matter R, Eckardt KU, Zapf J 1990 Erythropoiesis, serum erythropoietin, and serum IGF-I in rats during accelerated growth. Acta Endocrinol (Copenh) 122:323-328
138. Froesch ER, Hussain M 1994 Recombinant human insulin-like growth factor-I: a therapeutic challenge for diabetes mellitus. Diabetologia 37: S179-S185
139. Han VK, D'Ercole AJ, Lund PK 1987 Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 236:193-197
140. Gosteli-Peter MA, Winterhalter KH, Schmid C, Froesch ER, Zapf J 1994 Expression and regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone. Endocrinology 135:2558-2567
141. Sussenbach JS, Steenbergh PH, Holthuizen P 1995 Structure and expression of the human insulin-like growth factor genes. Growth Regul 2:1-9
142. Daughaday WH, Rotwein P 1989 Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures. Endocr Rev 10:68-91
143. Rotwein P, Thomas MJ, Gronowski AM, Bichell DP, Kikuchi K 1994 The somatomedin hypothesis revisited: early events in growth hormone action. In: Baxter RC, Gluckman PD, Rosenfeld RG (eds) The Insulin-like Growth Factors and Their Regulatory Proteins. Elsevier, Amsterdam, pp 13-21
144. Arkins S, Rebeiz N, Biragyn A, Reese DL, Kelley KW 1993 Murine macrophages express abundant insulin-like growth factor-I class I Ea and Eb transcripts. Endocrinology 133:2334-2343
145. Nyman T, Pekonen F 1993 The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes. Acta Endocrinol (Copenh) 128:168-172
146. Dorshkind K 1990 Regulation of hemopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol 8:111-137
147. Abboud SL, Bethel CR, Aron SL 1991 Secretion of insulin-like growth factor I and insulin-like growth factor-binding proteins by murine bone marrow stromal cells. J Clin Invest 88:470-475
148. Yamada M, Hato F, Kinoshita Y, Tominaga K, Tsuji Y 1994 The indirect participation of growth hormone in the thymocyte proliferation system. Cell Mol Biol 40:111-121
149. Tanaka M, Hayashida Y, Sakaguchi K, Ohkubo T, Wakita M, Hoshino S, Nakashima K 1996 Growth hormone-independent expression of insulin-like growth factor I messenger ribonucleic acid in extrahepatic tissues of the chicken. Endocrinology 137:30-34
150. Murphy LJ, Friesen HG 1988 Differential effects of estrogens and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat. Endocrinology 122:325-332
151. Noble PW, Lake FR, Henson PM, Riches DWH 1993 Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha dependent mechanism in murine macrophages. J Clin Invest 91:2368-2377
152. Fournier T, Riches DW, Winston BW, Rose DM, Young SK, Noble PW, Lake FR, Henson PM 1995 Divergence in macrophage insulin-like growth factor-I (IGF-I) synthesis induced by TNF-alpha and prostaglandin E2. J Immunol 155:2123-2133
153. Arkins S, Rebeiz N, Brunke-Reese DL, Minshall C, Kelley KW 1995 The colony-stimulating factors induce expression of insulin-like growth factor-I messenger ribonucleic acid during hematopoiesis. Endocrinology 136:1153-1160
154. Arkins S, Rebeiz N, Brunke-Reese DL, Biragyn A, Kelley KW 1995 Interferon-gamma inhibits macrophage insulin-like growth factor-I synthesis at the transcriptional level. Mol Endocrinol 9:350-360
155. Tsuji Y, Kinoshita Y, Hato F, Tominaga K, Yoshida K 1994 The in vitro proliferation of thymus epithelial cells stimulated with growth hormone and insulin-like growth factor-I. Cell Mol Biol 40:1135-1142
156. Dardenne M, Savino W, Gagnerault M-C, Itoh T, Bach J-F 1989 Neuroendocrine control of thymic hormonal production. I. Prolactin stimulates in vivo and in vitro the production of thymulin and murine thymic epithelial cells. Endocrinology 125:3-12
157. Murphy WJ, Durum SK, Longo DL 1992 Role of neuroendocrine hormones in murine T cell development: growth hormone exerts thymopoietic effects in vivo. J Immunol 149:3851-3857
158. Berczi I, Nagy E, de Toledo SM, Matusik RJ, Friesen HG 1991 Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue. J Immunol 146:2201-2206
159. Clayton PE, Day RN, Silva CM, Hellmann P, Day KH, Thorner MO 1994 Growth hormone induces tyrosine phosphorylation but does not alter insulin-like growth factor-I gene exprression in human IM-9 lymphocytes. J Mol Endocrinol 13:127-136
160. Merrimee TJ, Grant MB, Broder CM, Cavalli-Sforza LL 1989 Insulin-like growth factor secretion by human B-lymphocytes: a comparison of cells from normal and pygmy subjects. J Clin Endocrinol Metab 69:978-984
161. Geffner ME, Bersch N, Lippe BM, Rosenfeld RG, Hintz RL, Golde DW 1990 Growth hormone mediates the growth of T-lympohblast cell lines via locally generated insulin-like growth factor I. J Clin Endocrinol Metab 71:464-469
162. Baier TG, Jenne EW, Blum W, Schonberg D, Hartmann KK 1992 Influence of antibodies against IGF-I, insulin or their receptors on proliferation of human acute lymphoblastic leukemia cell lines. Leuk Res 16:807-814
163. Siddle K, Soos MA, Field CE, Nave BT 1994 Hybrid and atypical insulin/insulin-like growth factor-I receptors. Horm Res 41[Suppl 2]:56-65
164. LeRoith D, Werner H, Beitner-Johnson D, Roberts CTJ 1995 Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 143-163
165. Nicola NA 1989 Hemopoietic cell growth factors and their receptors. Annu Rev Biochem 58:45-77
166. Nissley P, Lopaczynski W 1991 Insulin-like growth factor receptors. Growth Factors 5:29-49
167. Ellis MJC, Leav BA, Yang Z, Rasmussen A, Pearce A, Zweibel JA, Lippman ME, Cullen KJ 1996 Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Mol Endocrinol 10:286-297
168. Nissley SP, Kiess W 1991 Binding of insulin-like growth factor-II (IGF-II) and lysosomal enzymes to the IGF-II/mannose-6-phosphate receptor. In: Spencer EM (ed) Modern Concepts of Insulin-like Growth Factors. Elsevier, Amsterdam, pp 419-430
169. Gavin JR, Buell DN, Roth J 1972 Water soluble insulin receptors form human lymphocytes. Science 178:168-169
170. Helderman JH, Strom TB 1978 Specific insulin binding site on T and B lymphocytes as a marker for cell activation. Nature 274:62-63
171. Lee PD, Rosenfeld RG, Hintz RL, Smith SD 1986 Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts. J Clin Endocrinol Metab 62:28-35
172. Kozak RW, Haskell JF, Greenstein LA, Rechler MM, Waldmann TA, Nissley SP 1987 Type I and II insulin-like growth factor receptors on human phytohemagglutinin-activated T lymphocytes. Cell Immunol 109:318-331
173. Tapson VF, Boni-Schnetzler M, Pilch PF, Center DM, Berman JS 1988 Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro. J Clin Invest 82:950-957
174. Stuart CA, Meehan RT, Neale LS, Cintron NM, Furlanetto RW 1991 Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes. J Clin Endocrinol Metab 72:1117-1122
175. Kooijman R, Willems M, De Haas CJ, Rijkers GT, Schuurmans AL, Van Buul-Offers SC, Heijnen CJ, Zegers BJ 1992 Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells. Endocrinology 131:2244-2250
176. Xu X, Mardell C, Xian CJ, Zola H, Read LC 1995 Expression of functional insulin-like growth factor-1 receptor on lymphoid cell subsets of rats. Immunology 85:394-399
177. Hartmann KK, Baier TG, Papa V, Kronenwett M, Brown EJ, Goldfine ID, Rosenthal SM 1992 A monoclonal antibody to the T-cell receptor increases IGF-I receptor content in normal T-lymphocytes: comparison with phytohemagglutinin. J Cell Biochem 48:81-85
178. Schillaci R, Ribaudo CM, Rondinone CM, Roldan A 1994 Role of insulin-like growth factor-1 on the kinetics of human lymphocytes stimulation in serum-free culture medium. Immunol Cell Biol 72: 300-305
179. Kooijman R, Scholtens LE, Rijkers GT, Zegers BJ 1995 Type I insulin-like
180. Hattori Y, Vera JC, Rivas CI, Bersch N, Bailey RC, Geffner ME, Golde DW 1996 Decreased insulin-like growth factor I receptor expression and function in immortalized African Pygmy T cells. Endocrinology 81:2257-2263
181. Verland S, Gammeltoft S 1989 Functional receptors for insulin-like growth factors I and II in rat thymocytes and mouse thyoma cells. Mol Cell Endocrinol 67:207-216
182. Kooijman R, Lauf JJ, Kappers AC, Rijkers G 1995 Insulin-like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with phosphatidylinositol-3 kinase in human thymocytes. J Exp Med 182:593-597
183. Swisshelm K, Ryan K, Tsuchiya K, Sager R 1995 Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc Natl Acad Sci USA 92:4472-4476
184. Yamauchi T, Umeda F, Masakado M, Isaji M, Mizushima S, Nawata H 1994 Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells. Biochem J 303:591-598
185. Lassalle P, Molet S, Janin A, Heyden JV, Tavernier J, Fiers W, Devos R, Tonnel AB 1996 ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem 271:20458-20464
186. Baxter RC, Dai J, Holman S, Lewitt MS 1994 Determinants of complex formation between IGFBP-3 and the acid-labile subunit. In: Baxter RC, Gluckman PD, Rosenfeld RG (eds) The Insulin-like Growth Factors and Their Regulatory Proteins. Elsevier, Amsterdam, pp 227-235
187. Cox GN, McDermott MJ, Merkel E, Stroh CA, Ko S, Squires CH, Gleason TM, Russell D 1994 Recombinant human-insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-1 and growth hormone in hypophysectomized rats. Endocrinology 135:1913-1920
188. Grellier P, Yee D, Gonzalez M, Abboud SL 1995 Characterization of insulin-like growth factor binding proteins (IGFBP) and regulation of IGFBP-4 in bone marrow stromal cells. Br J Haematol 90:249-257
189. Tonner E, Beattie J, Flint DJ 1995 Production of insulin-like growth factor binding protein (IGFBP), IGFBP-3 protease, and expression of IGF-I receptors by cells of the sheep immune system. Eur J Endocrinol 132:118-122
190. Schwander J, Mary JL 1993 The RIA for IGFBP-2 in man: a meagre catch? Growth Regul 3:104-108
191. Blum WF, Horn N, Kratzsch J, Jorgensen JO, Juul A, Teale D, Mohnike K, Ranke MB 1993 Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regul 3:100-104
192. Mohnike K, Kluba U, Blum WF, Aumann V, Vorwerk P, Mittler U 1995 Serum concentrations of insulin-like growth factors (IGF)-I and IGF-II and IGF binding proteins (IGFBP)-2 and IGFBP-3 in 49 children with ALL, NHL or solid tumors [German]. Klin Padiatr 207:225-229
193. Wimmer K, Biemer E, Elmlinger MW, Dannecker L, Blum WL, Ranke MB, Dannecker GE 1995 IGFBP-2 is differentially expressed in leukemic T- and B-cell lines. Program of the 3rd International Symposium on IGFBPs. Tubingen, Germany, pp
194. Pintar JE, Schuller A, Cerro JA, Czick M, Grewal A, Green B 1995 Genetic ablation of IGFBP-2 suggests functional redundancy in the IGFBP family. Prog Growth Factor Res 6:437-445
195. Dai Z, Xing Y, Boney CM, Clemmons DR, D'Ercole AJ 1994 Human Insulin-like growth factor-binding protein-1 (hIGFBP-1) in transgenic mice: characterization and insights into the regulation of IGFBP-1 expression. Endocrinology 135:1316-1327
196. Rajkumar K, Barron D, Lewitt MS, Murphy LJ 1995 Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 136:4029-4034
197. Murphy L, Rajkumar K, Molnar P 1995 Phenotypic manifestations of insulin-like growth factor binding protein-1 (IGFBP-1) and IG-FBP-3 overexpression in transgenic mice. Prog Growth Factor Res 6:425-432
198. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Selzinger BR, Kley N 1995 Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649
199. Dorshkind K 1996 Growth and differentiation factors that regulate B lymphocyte development. In: Herzenberg LA, Weir DM (eds) Handbook of Experimental Immunology. Blackwell Science, Cambridge MA, in press
200. Landreth K, Narayanan R, Dorshkind K 1992 Insulin-like growth factor-I regulates pro-B-cell differentiation. Blood 80:1-6
201. Gibson LF, Piktel D, Landreth KS 1993 Insulin-like growth factor-1 potentiates expansion of interleukin-7-dependent pro-B cells. Blood 82:3005-3011
202. Landreth KS, Englehard D, Beare MH, Kincade PW, Kapoor N, Good RA 1985 Regulation of human B lymphopoiesis; effect of a urinary activity associated with cyclic neutropenia. J Immunol 134: 2305-2309
203. Kincade PW 1987 Experimental models for understanding B lymphocyte formation. Adv Immunol 41:181-267
204. Funk P, Kincade PW, Witte PL 1994 Native associations of early hematopoietic stem cells and stromal cells involved in cell aggregates. Blood 83:361-369
205. Jardieu P, Clark R, Mortensen D, Dorshkind K 1994 In vivo administration of insulin-like growth factor-1 stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation. J Immunol 152:4320-4327
206. Robbing K, McCabe S, Scheiner T, Strasser J, Clark R, Jardieu P 1994 Immunological effects of insulin-like growth factor-I: enhancement immunoglobulin synthesis. Clin Exp Immunol 95:337-342
207. Clark R, Mortensen DL, Carlsson L 1995 Insulin-like growth factor-I and growth hormone (GH) have distinct and overlapping anabolic effects in GH-deficient rats. Endocrine 3:297-304
208. Geffner ME, Bersch N, Golde DW 1992 Insulin and IGF-I stimulate normal and virally transformed T-lymphocyte cell growth in vitro. Brain Behav Immun 6:377-386
209. Murphy WJ, Durum SK, Anver MR, Longo DL 1992 Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice. J Immunol 148:3799-3805
210. Gjerset RA, Yeargin J, Volkman SK, Vila V, Arya J, Haas M 1990 Insulin-like growth factor-I supports proliferation of autocrine thymic lymphoma cells with a pre-T cell phenotype. J Immunol 145: 3497-3501
211. Taub DD, Tsarfaty G, Lloyd AR, Durum SK, Longo DL, Murphy WJ 1994 Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic. J Clin Invest 94:293-300
212. Clark RG, Mortensen DL, Figari I, Jardieu P, Anabolic and immunologic effects of IGF-1 and GH given alone and together to aged rats. Program of the 76th Annual Meeting of The Endocrine Society, Anaheim, CA, 1994, p 296
213. van Buul-Offers SC, Ueda I, Van den Brande JL 1986 Biosynthetic somatomedin C (SM-C/IGF-I) increases the length and weight of Snell dwarf mice. Pediatr Res 20:825-827
214. Woodall SM, Breier BH, O'Sullivan U, Gluckman PD 1991 The effect of the frequency of subcutaneous insulin-like growth factor-1 administration on weight gain in growth hormone deficient mice. Horm Metab Res 23:581-584
215. Cottam YH, Blair HT, Gallaher BW, Purchas RW, Breier BH, McCutcheon SN, Gluckman PD 1992 Body growth, carcass composition, and endocrine changes in lambs chronically treated with recombinantly derived insulin-like growth factor-I. Endocrinology 130:2924-2930
216. LeRoith D, Yanowski J, Kaldjian EP, Jaffe ES, LeRoith T, Purdue K, Cooper BD, Pyle R, Adler W 1996 The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys. Endocrinology 137:1071-1079
217. D'Ercole J 1993 Expression of insulin-like growth factor-1 in transgenic mice. Ann NY Acad Sci 692:149-160
218. Siddiqui RA, McCutcheon SN, Blair HT, Mackenzie DD, Morel PC, Breier BH, Gluckman PD 1992 Growth allometry of organs, muscles and bones in mice from lines divergently selected on the basis of plasma insulin-like growth factor-I. Growth Dev Aging 56:53-60
219. Kooijman R, van Buul-Offers SC, Scholtens LE, Schuurman HJ, van den Brande LJ, Zegers BJ 1995 T cell development in insulin-like growth factor-II transgenic mice. J Immunol 154:5736-5745
220. van Buul-Offers SC, de Haan K, Reijnen-Gresnigt MG, Meinsma D, Jansen M, Oei SL, Bonte EJ, Sussenbach JS, Van den Brande JL 1995 Overexpression of human insulin-like growth factor-II in transgenic mice causes increased growth of the thymus. J Endocrinol 144:491-502
221. Nielsen FC, Ostergaard L, Nielsen J, Christiansen J 1995 Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway. Nature 377:358-362
222. Kimata H, Yoshida A 1994 Effect of growth hormone and insulin-like growth factor-I on immunoglobulin production by and growth of human B-cells. J Clin Endocrinol Metab 78:635-641
223. Binz K, Joller P, Froesch P, Zapf J, Froesch ER 1990 Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I. Proc Natl Acad Sci USA 87:3690-3694
224. Beschorner WE, Divic J, Pulido H, Yao X, Kenworthy P, Bruce G 1991 Enhancement of thymic recovery after cyclosporine by recombinant human growth hormone and insulin-like growth factor I. Transplantation 52:879-884
225. Murphy WJ, Durum SK, Longo DL 1992 Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice. Proc Natl Acad Sci USA 89:4481-4485
226. Krammer P, Behrmann I, Daniel P, Dhein J, Debatin K-M 1994 Regulation of apoptosis in the immune system. Curr Opin Immunol 6:279-289
227. Harrington EA, Bennett MR, Fanidi A, Evan GI 1994 CMyc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13:3286-3295
228. Baserga R 1995 The insulin-like growth factor receptor: a key to tumor growth? Cancer Res 55:249-252
229. Hammerman MR, Miller SB 1994 Therapeutic use of growth factors in renal failure. J Am Soc Nephrol 5:1-11
230. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM 1995 Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA 92:8031-8035
231. Guan J, Williams C, Gunning M, Mallard C, Gluckman P 1993 The effects of IGF-1 treatment after hypoxic-ischemic brain injury in adult rats. J Cereb Blood Flow Metab 13:609-616
232. Rodriguez-Tarduchy G, Collins MKL, Garcia I, Lopez-Rivas A 1992 Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells. J Immunol 149:535-540
233. Kincade PW, Medina KL, Smithson G, Scott DC 1994 Pregnancy: a clue to normal regulation of B lymphopoiesis. Immumol Today 15:539-544
234. Clarke AG, Kendall MD 1994 The thymus in pregnancy: the interplay of neural, endocrine and immune influences. Immunol Today 15:545-551
235. Cross RJ, Bryson JS, Roszman TL 1992 Immunologic disparity in the hypopituitary dwarf mouse. J Immunol 148:1347-1352
236. Montecino-Rodriguez E, Clark RG, Johnson A, Collins L, Dorshkind K 1996 Defective B cell development in Snell Dwarf (dw/ dw) mice can be corrected by thyroxine treatment. J Immunol 157:3334-3340
237. 3) affects absorption of immunolactoglobulins in calves. Reprod Nutr Dev 35:387-393
238. Phillips DI, Barker DJ, Osmond C 1993 Infant feeding, fetal growth and adult thyroid function. Acta Endocrinol (Copenh) 129: 134-138
239. Medina KL, Kincade PW 1994 Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. Proc Natl Acad Sci USA 91:5382-5386
240. Smithson G, Beamer WG, Shultz KL, Christianson SW, Shultz LD, Kincade PW 1994 Increased B lymphopoiesis in genetically sex steroid-deficient hypogonadal (hpg) mice. J Exp Med 180:717-720
241. Holder AT, Clark RG, Preece MA 1983 Prolonged oestrogen treatment inhibits growth hormone induced growth in hypopituitary dwarf mice. J Endocrinol 96:451-456
242. Ruan W, Catanese V, Wieczorek R, Feldman M, Kleinberg DL 1995 Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone-induced IGF-1 messenger ribonucleic acid. Endocrinology 136:1296-1302
243. Freyschuss B, Sahlin L, Masironi B, Eriksson H 1994 The hormonal regulation of the oestrogen receptor in rat liver: an interplay involving growth hormone, thyroid hormones and glucocorticoids. J Endocrinol 142:285-298
244. Cusi K, DeFronzo RA 1995 Treatment of NIDDM, IDDM, and other insulin-resistant states with IGF-I. Diabetes Rev 3:206-236
245. Polychronakos C, Giannoukakis N, Deal CL 1995 Imprinting of IGF2, insulin-dependent diabetes, immune function, and apoptosis: a hypothesis. Dev Genet 17:253-262
246. Bergerot I, Fabien N, Maguer V, Thivolet C 1995 Insulin-like growth factor-1 (IGF-1) protects NOD mice from insulitis and diabetes. Clin Exp Immunol 102:335-340
247. Ballard FJ, Tomas FM, Read LC, Knowles SE, Owens PC, Lemmey AB, Martin AA, Wells JRE, Wallace JC, Francis GL 1991 Effects of IGF-1 and IGF analogs on growth during catabolic states in rats. In: Spencer EM (ed) Modern Concepts of Insulin-like Growth Factors. Elsevier, Amsterdam, pp 617-627
248. Vanderhoof JA, McCusker RH, Clark RG, Mohammadpour H, Blackwood DJ, Harty RF, Park JH 1992 Truncated and native insulin-like growth factor-1 enhance mucosal adaptation after jejunoileal resection. Gastroenterology 102:1949-1956
249. Ziegler TR, Leader I 1994 Adjunctive human growth hormone therapy in nutrition support: potential to limit septic complications in intensive care unit patients. Semin Respir Infect 9:240-247
250. Huang KF, Chung DH, Herndon DN 1993 Insulin-like growth factor 1 (IGF-1) reduces gut atrophy and bacterial translocation after severe burn injury. Arch Surg 128:47-53
251. Morishima Y, Tashiro T, Takagi K, Yamamori H, Mashima Y, Nakajima N 1995 Effects of insulin-like growth factor-I in burned rats. [Japanese]. J Jpn Surg Soc 96:72-79
252. Chen K, Okuma T, Okamura K, Tabira Y, Kaneko H, Miyauchi Y 1995 Insulin-like growth factor-I prevents gut atrophy and maintains intestinal integrity in septic rats. J Parenter Enteral Nutr 19:119-124
253. Inoue T, Saito H, Fukushima R, Inaba T, Lin M-S, Fukatsu K, Muto T 1995 Growth hormone and insulin-like growth factor I enhance host defence in a murine model of sepsis. Arch Surg 130:1115-1122
254. Liao W, Rudling M, Angelin B 1996 Growth hormone potentiates the in vivo biological activities of endotoxin in the rat. Eur J Clin Invest 26:254-258
255. Elsasser TH, Caperna TJ, Rumsey TS 1995 Endotoxin administration decreases plasma insulin-like growth factor (IGF)-I and IGF-binding protein-2 in Angus x Hereford steers independent of changes in nuritional intake. J Endocrinol 144:109-117
256. Fan J, Char D, Kolasa AJ, Pan W, Maitra SR, Patlak CS, Spolarics Z, Gelato MC, Lang CH 1995 Alterations in hepatic production and peripheral clearance of IGF-I after endotoxin. Am J Physiol 269: E33-E42
257. Kurtz A, Jelkmann W, Bauer C 1982 A new candidate for the regulation of erythropoiesis: insulin-like growth factor I. FEBS Lett 149:105-108
258. Claustres M, Chatelian P, Sultan C 1987 Insulin-like growth factor I stimulates human erythroid colony formation in vitro. J Clin Endocrinol Metab 65:78-82
259. Kurtz A, Zapf J, Eckardt K-U, Clemons G, Froesch RE 1988 Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats. Proc Natl Acad Sci USA 85:7825-7829
260. Liu J-P, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-1) and type-1 IGF receptor (IGFR). Cell 75: 59-72
261. Baker J, Liu J-P, Robertson EJ, Efstratiadis A 1993 Role of insulin-like growth factors in embryonic and post-natal growth. Cell 75: 73-82
262. Ratajczak MZ, Kuczynski WI, Onodera K, Moore J, Ratajczak J, Kregenow DA, DeReil K, Gerwitz AM 1994 A reappraisal of the role of insulin-like growth factor I in the regulation of human hematopotesis. J Clin Invest 94:320-327
263. Correa PN, Eskinazi D, Axelrad AA 1994 Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium. Blood 83:99-112
264. Mirza AM, Correa PN, Axelrad AA 1995 Increased basal and induced tyrosine phosphorylation of the insulin-like growth factor I receptor beta subunit in circulating mononuclear cells of patients with polycythemia vera. Blood 86:877-882
265. Prchal JT, Prchal JF 1994 Evolving understanding of the cellular defect in Polycythemia vera: implications for its clinical diagnosis and molecular pathophysiology (Editorial). Blood 83:1-4
266. Kelley KW, Dantzer R 1991 Growth hormone and prolactin as natural antagonists of glucocorticoids in immunoregulation. In: Plotnikoff N, Murgo A, Faith R, Wybran J (eds) Stress and Immunity. CRC Press, Boca Raton, FL, pp 433-452
267. Chatterton JRT, Murray CT, Hellman L 1973 Endocrine effects on leukocytopoiesis in the rat. Evidence for growth hormone secretion as the leukocytopoietic stimulus following acute cortisol-induced lymphocytopenia. Endocrinology 92:775-787
268. Hayashida T, Li CH 1957 The infuence of adrenocorticotropic and growth hormones on antibody formation. J Exp Med 105:93-98
269. Franco P, Marelli O, Lattuada D, Locatelli V, Cocchi D, Muller E 1990 Influence of growth hormone on the immunosuppressive effect of prednisolone in mice. Acta Endocrinol (Copenh) 123:339-344
270. Underwood LE 1988 Assessment of the risks of treatment with human growth hormone. In: Bereu B (ed) Basic and Clinical Aspects of Growth Hormone. Plenum Press, New York, pp 357-366
271. Hartman ML, Clayton PE, Johnson ML, Celniker A, Perlman AJ, Alberti KGMM, Thorner MO 1993 A low-dose euglycemic infusion of recombinant human insulin-like growth factor-1 rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J Clin Invest 91:2453-2462
272. Mauras N, Beaufrere B 1995 Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednison in humans without a diabetogenic effect. J Clin Endocrinol Metab 80:869-874
273. Powell-Braxton L, Warburton C, Gillett N 1994 Genetically engineered IGF-I deficient mice. In: Baxter RC, Gluckman PD, Rosenfeld RG (eds) The Insulin-like Growth Factors and Their Regulatory Proteins. Elsevier, Amsterdam, pp 247-252
274. Sullivan KM, Mori M, Sanders J, Siadak M, Witherspoon RP, Anansetti C, Appelbaum FR, Bensinger W, Bowden R, Buckner CD, Clark J, Crawford S, Deeg HJ, Doney K, Flowers M, Hansen J, Loughran T, Martin P, McDonald G, Pepe M, Petersen FB, Schuening F, Stewart P, Storb R 1992 Late complications of allogenic and autologous marrow transplantation. Bone Marrow Transplant 10:127-134
275. Mackall CL, Fleisher TA, Brown MR, Magrath IT, Shad AT, Horowitz ME, Wexler LH, Adde MA, McClure LL, Gress RE 1994 Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 84:2221-2228
276. Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Horowitz ME, Magrath IT, Shad AT, Steinberg SM, Gress RE 1995 Age thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332:143-149
277. Dong YL, Fleming RY, Huang KF, Herndon DN, Yan TZ, Waymack JP 1993 Effect of insulin-like growth factor 1 on host response to tumor. J Surg Oncol 53:121-127
278. Mulligan K, Grunfeld C, Hellerstein MK, Neese RA, Schambelan M 1995 Effects of recombinant human growth hormone on body composition and metabolism in HIV-assodated wasting. In: Blackman MR, Roth J, Harman SM, Shapiro JR (eds) GHRH, GH and IGF-1: Basic and Clinical Advances. Springer-Verlag, New York, pp 75-91
279. Waters DL, Hardy KJ, Danska J, Nickell D, Quails C, Jackson L, Gesundheit N, Watson D, Nightingale S, Koster F, Schade DS, A double-blind placebo-controlled randomized clinical trial of growth hormone and IGF-I in AIDS wasting. Program of the 76th Annual Meeting of The Endocrine Society, Anaheim, CA, 1994 (Abstract 17)
280. Westermann J, Pabst R 1990 Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? Immunol Today 11: 406-410
281. Laurence J, Grimison B, Gonenne A 1992 Effect of recombinant human growth hormone on acute and chronic human immunodeficiency virus infection in vitro. Blood 79:467-472
282. Germinario R, DeSantis T, Wainberg M 1995 Insulin-like growth factor 1 and insulin inhibit HIV type 1 replication in cultured cells. AIDS Res Hum Retroviruses 11:555-561
283. Tsarfaty G, Longo DL, Murphy WJ 1994 Human insulin-like growth factor I exerts hematopoietic growth-promoting effects after in vivo administration. Exp Hematol 22:1273-1277
284. Clark RG, Jardieu P 1994 Anabolic and immunologic activity of recombinant human insulin-like growth factor-I (rhIGF-I) in AZT-treated mice. Growth Regul 4:123 (Abstract)
285. Murphy WJ, Tsarfaty G, Longo D 1992 Growth hormone exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymidine. Blood 80: 1443-1447
286. Beck KD, Powell-Braxton L, Widmer HR, Valverde J, Hefti F 1995 IGF-1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 14:717-730
287. Yao DL, Liu X, Hudson LD, Webster HD 1995 Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 92:6190-6194